Evidence map›Paper›PMID 40557969›Full record

ArticleMolecular informatics2025

Drug Search and Design Considering Cell Specificity of Chemically Induced Gene Expression Profiles for Disease-Associated Tissues.

Chikashige Yamanaka, Michio Iwata, Kazuma Kaitoh, Yoshihiro Yamanishi

Abstract read
In one paragraph

Article in Molecular informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chikashige YamanakaDepartment of Bioscience and Bioinformatics, Faculty of Computer Science and Systems Engineering, Kyushu Institute of Technology, Fukuoka, Japan.
Michio IwataDepartment of Bioscience and Bioinformatics, Faculty of Computer Science and Systems Engineering, Kyushu Institute of Technology, Fukuoka, Japan.
Kazuma KaitohGraduate School of Informatics, Nagoya University, Nagoya, Japan.
Yoshihiro YamanishiDepartment of Bioscience and Bioinformatics, Faculty of Computer Science and Systems Engineering, Kyushu Institute of Technology, Fukuoka, Japan.ORCID https://orcid.org/0000-0003-2279-8773

Funding

AMED JP22nk0101111AMED JP23nk0101111JSPS KAKENHI 20H05797JSPS KAKENHI 21H04915JSPS KAKENHI 21K18327
6 · The paper itself

Abstract

The use of omics data, including gene expression profiles, has recently gained increasing attention in drug discovery. Omics-based drug searches and designs are often based on the correlations between chemically induced and disease-induced gene expression profiles; however, the cell specificity has not been considered. In this study, we designed a novel computational method for drug search and design using cell-specific correlations between drugs and diseases. A data completion technique allowed the characterization of cell-specific gene expression patterns in diseased cells. This proposed method was applied to search for drug candidates and generate new chemical structures for gastric cancer and atopic dermatitis. The results of drug search demonstrated that compounds with diverse chemical structures were detected and were associated with target diseases at the molecular pathway levels. The results of drug design also demonstrated that newly generated compounds were reasonable in terms of the reproducibility of registered drugs. The proposed method is expected to be useful for omics-based drug discovery.

Indexed as

Drug DesignDrug DiscoveryGene Expression ProfilingTranscriptomeDermatitis, AtopicHumansStomach Neoplasmscell specificitydrug designgene expression

Identifiers

PMID40557969
PMCPMC12188700

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.